EFFECT OF 3 WEEKS TREATMENT WITH YOHIMBINE ON SALIVARY SECRETION IN HEALTHY-VOLUNTEERS AND IN DEPRESSED-PATIENTS TREATED WITH TRICYCLIC ANTIDEPRESSANTS

被引:12
作者
BAGHERI, H
SCHMITT, L
BERLAN, M
MONTASTRUC, JL
机构
[1] CHU TOULOUSE,FAC MED,PHARMACOL MED & CLIN LAB,INSERM,U317,37 ALLEES JULES GUESDE,F-31073 TOULOUSE,FRANCE
[2] CHU PURPAN,SERV HOSP UNIV PSYCHIAT,F-31059 TOULOUSE,FRANCE
关键词
YOHIMBINE; SALIVARY SECRETION; TRICYCLIC ANTIDEPRESSANTS; ALPHA-2-ADRENOCEPTORS; ALPHA-2-ADRENOCEPTOR ANTAGONISTS;
D O I
10.1111/j.1365-2125.1992.tb05661.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of yohimbine treatment (4 mg three times daily) for 3 weeks on salivary secretion was investigated. In healthy volunteers, acute administration of yohimbine increased salivary volume within 1 h to a similar extent before and at the end of the treatment period. In depressed patients treated with tricyclic antidepressants (and exhibiting a reduced salivary flow), yohimbine also acutely increased salivary volume. In contrast, the alpha2-adrenoceptor antagonist failed to modify resting values measured in the morning (i.e. 10 and 14 h after the last administration in healthy volunteers and depressed patients respectively). This result indicates that alpha2-adrenoceptor antagonists may have a potential therapeutic use in the treatment of dry mouth caused by tricyclic antidepressant drugs.
引用
收藏
页码:555 / 558
页数:4
相关论文
共 12 条
  • [1] IS YOHIMBINE-INDUCED INCREASE IN SALIVARY SECRETION A KININ-DEPENDENT MECHANISM
    BAGHERI, H
    BOMPART, G
    GIROLAMI, JP
    MONTASTRUC, JL
    MONTASTRUC, P
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1992, 6 (01) : 17 - 20
  • [2] BLACKWELL B, 1978, AM J PSYCHIAT, V135, P722
  • [3] YOHIMBINE INCREASES HUMAN SALIVARY SECRETION
    CHATELUT, E
    RISPAIL, Y
    BERLAN, M
    MONTASTRUC, JL
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (03) : 366 - 368
  • [4] GALITZKY J, 1990, EUR J CLIN PHARMACOL, V39, P447
  • [5] YOHIMBINE INCREASES SUBMAXILLARY KALLIKREIN RELEASE INTO THE SALIVA IN DOGS - EVIDENCE FOR ALPHA-2-ADRENOCEPTOR-MEDIATED INHIBITION OF CHOLINERGIC PATHWAYS
    GIROLAMI, JP
    BASCANDS, JL
    PECHER, C
    BERLAN, M
    MONTASTRUC, JL
    MONTASTRUC, P
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1991, 102 (02) : 351 - 354
  • [6] GOLDBERG MR, 1983, PHARMACOL REV, V35, P143
  • [7] YOHIMBINE BIOAVAILABILITY IN HUMANS
    GUTHRIE, SK
    HARIHARAN, M
    GRUNHAUS, LJ
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (04) : 409 - 411
  • [8] EFFECT OF YOHIMBINE ON BLOOD-PRESSURE IN PATIENTS WITH DEPRESSION AND ORTHOSTATIC HYPOTENSION INDUCED BY CLOMIPRAMINE
    LACOMBLEZ, L
    BENSIMON, G
    ISNARD, F
    DIQUET, B
    LECRUBIER, Y
    PUECH, AJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (03) : 241 - 251
  • [9] DETERMINATION OF YOHIMBINE AND ITS 2 HYDROXYLATED METABOLITES IN HUMANS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND MASS-SPECTRAL ANALYSIS
    LEVERGE, R
    LECORRE, P
    CHEVANNE, F
    DEMAINDREVILLE, MD
    ROYER, D
    LEVY, J
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 574 (02): : 283 - 292
  • [10] EFFECTS OF YOHIMBINE ON SUBMAXILLARY SALIVATION IN DOGS
    MONTASTRUC, P
    BERLAN, M
    MONTASTRUC, JL
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1989, 98 (01) : 101 - 104